A large number of pediatric disorders occur as a result of inborn errors occurring in the metabolic pathways of amino acids or organic acids. These diseases are common pediatric problems with dramatic clinical presentations. Their initial clinical presentations differ according to age. A convenient manner of classification is as follows:
- 1.
Diseases of neonatal onset. The first clinical symptoms appear soon after birth or within the first few weeks of life. Such diseases are always associated with central nervous system (CNS) symptoms. Occasionally an infant will be born with an encephalopathic picture and stupor, with profoundly disturbed neurologic function at birth. More often, an infant normal at birth will soon develop lethargy, progressing rapidly into coma in association with other severe neurologic signs. The disease will cause neurologic handicaps and death if intervention is not prompt. These diseases are therefore called “devastating metabolic diseases of the newborn.” In...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acosta PB (1992) Ross metabolic formula system nutrition support protocols. Abbott Laboratories, Columbus
Adams PL, Lightowlers RN, Turnbull DM (1997) Molecular analysis of cytochrome c oxidase deficiency in Leigh’s syndrome. Ann Neurol 41:268–270
Al Aqeel A, Ozand PT, Gascon GG et al (1991) Biopterin-dependent hyperphenylalaninemia due to deficiency of 6-pyruvoyltetrahydropterin synthase. Neurology 41:730–737
Al Aqeel A, Rashed M, Ozand PT et al (1994) 3-Methylglutaconic aciduria: ten new cases with a possible new phenotype. Brain Dev 16(Suppl):23–32
Al-Essa M, Ozand PT (1998) Manual of metabolic diseases. King Faisal Specialist Hospital and Research Centre, Riyadh
Al-Essa M, Sakati N, Ozand PT (1997) An atlas of common metabolic and genetic diseases. King Faisal Specialist Hospital and Research Centre, Riyadh
Al-Essa M, Rahbeeni Z, Jumaah S et al (1998) Infections complications of propionic acidemia in Saudia Arabia. Clin Genet 54:90–94
Allanson J, McInnes R, Bradley L et al (1991) Combined, transient, and peripheral defects in tetrahydrobiopterin synthesis. J Pediatr 118:261–263
Arens R, Gozal D, Jain K et al (1993) Prevalence of medium-chain acylcoenzyme A dehydrogenase deficiency in the sudden infant death syndrome. J Pediatr 122:715–718
Arion WJ, Canfield WK (1993) Glucose-6-phosphatase and type 1 glycogen storage disease: some critical considerations. Eur J Pediatr 152(Suppl 1):S7–S13
Bellini C, Cerone R, Bonacci W et al (1992) Biochemical diagnosis and outcome of 2 years treatment in patient with combined methylmalonic aciduria and homocystinuria. Eur J Pediatr 151:818–820
Berardelli A, Thompson PD, Zaccagnini M et al (1991) Two sisters with generalized dystonia associated with homocystinuria. Mov Disord 6:163–165
Berry GT, Heidenreich R, Kaplan P et al (1991) Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease. N Engl J Med 324:175–179
Beutler E (1991) Galactosemia: screening and diagnosis. Clin Biochem 24:293–300
Bianchi L (1993) Glycogen storage disease I and hepatocellular tumors. Eur J Pediatr 152(Suppl 1):S63–S70
Blau N, Ichinose H, Nagatsu T et al (1995) A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program. J Pediatr 126:401–405
Brismar J, Ozand PT (1994) CT and MR of the brain in the diagnosis of organic acidemias: experiences from 107 patients. Brain Dev 16(Suppl):104–124
Brismar J, Ozand PT (1995) CT and MRI of the brain in glutaric acidemia type 1: a review of 59 published cases and a report of 5 new patients. AJNR Am J Neuroradiol 16:675–683
Brown GK, Brown RM, Scholem RD et al (1989) The clinical and biochemical spectrum of human pyruvate dehydrogenase complex deficiency. Ann NY Acad Sci 573:360–368
Budd MA, Tanaka K, Holmes LB et al (1967) Isovaleric acidemia: clinical features of a new genetic defect of leucine metabolism. N Engl J Med 277:321–327
Burke G, Robinson K, Refsum H et al (1992) Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med 326:69–70
Burri BJ, Sweetman L, Nyhan WL (1981) Mutant holocarboxylase synthetase: evidence for the enzyme defect in early infantile biotin-responsive multiple carboxylase deficiency. J Clin Invest 68:1491–1495
Byrd DJ, Krohm H-P, Winkler L et al (1989) Neonatal pyruvate dehydrogenase deficiency with lipoate responsive lactic acidaemia and hyperammonaemia. Eur J Pediatr 148:543–547
Carbone MA, MacKay N, Ling M et al (1998) Amerindian pyruvate carboxylase deficiency is associated with two distinct missense mutations. Am J Hum Genet 62:1312–1319
Chen YT (1991) Type 1 glycogen storage disease: kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 5:71–76
Chen YT, Bazarre CH, Lee MM et al (1993) Type 1 glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr 152(Suppl 1):S56–S59
Coates PM (1994) New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders. Eur J Pediatr 153(Suppl 1):S49–S56
Costeff H, Elpeleg O, Apter N et al (1993) 3-Methylglutaconic aciduria in “optic atrophy plus”. Ann Neurol 33:103–104
Cox DW (1995) Genes of the copper pathway. Am J Hum Genet 56:828–834
Croffie JM, Gupta SK, Chong SK et al (1999) Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. Pediatrics 103:675–678
D’Angio CT, Dillon MJ, Leonard JV (1991) Renal tubular dysfunction in methylmalonic acidaemia. Eur J Pediatr 150:259–263
De Raeve L, De Meirleir L, Ramet J et al (1994) Acrodermatitis entheropathica-like cutaneous lesions in organic aciduria. J Pediatr 124:416–420
De Vivo DC (1993) The expanding clinical spectrum of mitochondrial diseases. Brain Dev 15:1–22
Dhondt JL (1991) Strategy for the screening of tetrahydrobiopterin deficiency among hyperphenylalaninemia patients: 15-years experience. J Inherit Metab Dis 14:117–127
Donadieu J, Bader-Meunier B, Bertrand Y et al (1994) Recombinant human G-CSF (Lenogastrim) for infectious complications in glycogen storage disease type 1b: report of 7 cases. Nouv Rev Franc Hematol 35:529–534
Duran M, Beemer FA, Tibosch AS et al (1982) Inherited 3-methylglutaconic aciduria in two brothers – another defect of leucine metabolism. J Pediatr 101:551–554
Eisensmith RC, Woo SL (1991) Phenylketonuria and the phenylalanine hydroxylase gene. Mol Biol Med 8:3–18
Gartner J, Valle D (1993) The 70 kDa peroxisomal membrane protein: an ATP-binding cassette transporter protein involved in peroxisome biogenesis. Semin Cell Biol 4:45–52
Geisbrecht BV, Collins CS, Reuber BE et al (1998) Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. Proc Natl Acad Sci USA 95:8630–8635
Geraghty MT, Perlman EJ, Martin LS et al (1992) Cobalamin C defect associated with hemolytic-uremic syndrome. J Pediatr 120:934–937
Gibson KM, Breuer J, Nyhan WL (1988) 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients. Eur J Pediatr 148:180–186
Gibson KM, Sherwood WG, Hoffman GF et al (1991) Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduria. J Pediatr 118:885–890
Gitzelmann R, Bosshard NU (1993) Defective neutrophil and monocyte functions in glycogen storage disease type 1b: a literature review. Eur J Pediatr 152(Suppl 1):S33–S38
Greene HL, Swift LL, Knapp HR (1991) Hyperlipidemia and fatty acid composition in patients treated for type 1A glycogen storage disease. J Pediatr 119:398–403
Gregersen N, Christensen MF, Christensen E et al (1986) Riboflavin responsive multiple acyl CoA dehydrogenation deficiency: assessment of 3 years of riboflavin treatment. Acta Paediatr Scand 75:676–681
Hamosh A, McDonald JW, Valle D et al (1992) Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 122:324–325
Haworth JC, Booth FA, Chudley AE et al (1991) Phenotypic variability in glutaric aciduria type 1: report of fourteen cases in five Canadian Indian kindreds. J Pediatr 118:52–58
Henriquez H, Eldin A, Ozand PT et al (1994) Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched-chain amino acidemia (MSUD). Brain Dev 16(Suppl):86–93
Hommes FA (1993) Inborn errors of fructose metabolism. Am J Clin Nutr 58(Suppl):788S–795S
Hu FL, Gu Z, Kozich V et al (1993) Molecular basis of cystathionine betasynthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet 2:1857–1860
Huemer M, Muehl A, Wandl-Vergesslich K et al (1998) Stroke-like encephalopathy in an infant with 3-hydroxy-3-methyl-CoA lyase deficiency. Eur J Pediatr 157:743–746
Inoue S, Kreiger I, Sarnaik A et al (1981) Inhibition of bone marrow stem cell growth in vitro by methylmalonic acid: a mechanism for pancytopenia in a patient with methylmalonic acidemia. Pediatr Res 15:95–98
Kahler SG, Sherwood WG, Woolf D et al (1994) Pancreatitis in patients with organic acidemias. J Pediatr 124:239–243
Kakinoki H, Kobayashi K, Terazono H et al (1997) Mutations and DNA diagnoses of classical citrullinemia. Hum Mutat 9:250–259
Kaler SG (1994) Menkes disease. Adv Pediatr 41:263–304
Kaplan P, Mazur A, Field M et al (1991) Intellectual outcome in children with maple syrup urine disease. J Pediatr 119:46–50
Kelley RI, Cheatham JP, Clark BJ et al (1991) X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr 119:738–747
Kiuchi T, Edamoto Y, Kaibori M et al (1999) Auxiliary liver transplantation for urea-cycle enzyme deficiencies: lessons from three cases. Transplant Proc 31:528–529
Koch TK, Schmidt KA, Wagstaff JE et al (1992) Neurologic complications in galactosemia. Pediatr Neurol 8:217–220
Kodama H (1993) Recent developments in Menkes disease. J Inherit Metab Dis 16:791–799
Kyllerman M, Skjeldal OH, Lundberg M et al (1994) Dystonia and dyskinesia in glutaric aciduria type 1: clinical heterogeneity and therapeutic considerations. Mov Disord 9:22–30
Laberge C, Lescault A, Tanguay RM (1986) Hereditary tyrosinemias (type 1): a new vista on tyrosine toxicity and cancer. Adv Exp Med Biol 206:209–221
Larnaout A, Mongalgi MA, Kaabachi N et al (1998) Methylmalonic acidaemia with bilateral globus pallidus involvement: a neuropathological study. J Inherit Metab Dis 21:639–644
Lehnert W, Sperl W, Suormola T et al (1994) Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients. Eur J Pediatr 153(7 Suppl):S68–S80
Lei KJ, Shelly LL, Lin B et al (1995) Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. J Clin Invest 95:234–240
Lieberman ER, Gomperts ED, Shaw KN et al (1993) Homocystinuria: clinical and pathologic review, with emphasis on thrombotic features, including pulmonary artery thrombosis. Perspect Pediatr Pathol 17:125–147
Lindstedt S, Holme E, Lock EA et al (1992) Treatment of hereditary tyrosinaemia type 1 by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340:813–817
Lo WD, Sloan HR, Sotos JF et al (1993) Late clinical presentation of partial carbamyl phosphate synthetase I deficiency. Am J Dis Child 147:267–269
Loehr JP, Goodman SI, Frerman FE (1990) Glutaric aciduria type 2: heterogeneity of clinical and biochemical types. Pediatr Res 27:311–315
Maestri NE, Hauser ER, Bartholomew D et al (1991) Prospective treatment of urea cycle disorders. J Pediatr 119:923–928
Mandell R, Packman S, Laframboise R et al (1996) Use of amniotic fluid amino acids in prenatal testing for argininosuccinic aciduria and citrullinaemia. Prenat Diagn 16:419–424
Matalon R, Michals K (1991) Phenylketonuria: screening, treatment and maternal PKU. Clin Biochem 24:337–342
Matsuda I, Tanase S (1997) The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency. Am J Med Genet 71:378–383
Matsui SM, Mahoney MJ, Rosenberg LE (1983) The natural history of the inherited methylmalonic acidemias. N Engl J Med 308:857–861
Mayatepek E (1999) 5-Oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle. Eur J Pediatr 158:221–225
Mayatepek E, Kurczynski TW, Hoppel CL (1991) Long-term L-carnitine treatment in isovaleric acidemia. Pediatr Neurol 7:137–140
Melnyk AR, Matalon R, Henry BW et al (1993) Prospective management of a child with neonatal citrullinemia. J Pediatr 122:96–98
Morsy MA, Caskey CT (1994) Ornithine transcarbamylase deficiency: a model for gene therapy. Adv Exp Med Biol 368:145–154
Munnich A, Saudubray JM, Taylor J et al (1982) Congenital lactic acidosis, alpha-ketoglutaric aciduria and variant form of maple syrup urine disease due to a single enzyme defect: dihydrolipoyl dehydrogenase deficiency. Acta Paediatr Scand 71:167–171
Nagai T, Yokoyama T, Hasegawa T et al (1992) Fructose and glucagon loading in siblings with fructose-1, 6-diphosphatase deficiency in fed state. J Inherit Metab Dis 15:720–722
Naida S, Moser HW (1990) Peroxisomal disorders. Neurol Clin 8:507–528
Naito E, Kuroda Y, Toshima K et al (1989) Effect of sodium dichloroacetate on human pyruvate metabolism. Brain Dev 11:195–197
Northrup H, Sigman ES, Hebert AA (1993) Exfoliative erythroderma resulting from inadequate intake of branched-chain amino acids in infants with maple syrup urine disease. Arch Dermatol 129:384–385
Ozand PT, Gascon GG (1991) Organic acidurias: a review. Part 1 and part 2. J Child Neurol 6:196–219, 288–303
Ozand PT, Al Aqeel A, Gascon G et al (1991) 3-Hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis 14:174–188
Ozand PT, Rashed M, Gascon GG et al (1994a) Unusual presentations of propionic acidemia. Brain Dev 16(Suppl):46–57
Ozand PT, Rashed M, Gascon GG et al (1994b) 3-Ketothiolase deficiency: a review and four new patients with neurologic symptoms. Brain Dev 16(Suppl):38–45
Peinemann F, Danner DJ (1994) Maple syrup urine disease 1954 to 1993. J Inherit Metab Dis 17:3–15
Pomponio RJ, Hymes J, Reynolds TR et al (1997) Mutations in the human biotinidase gene that cause profound biotinidase deficiency in symptomatic children: molecular, biochemical, and clinical analysis. Pediatr Res 42:840–848
Ponzone A, Guardamagna O, Ferraris S et al (1991) Tetrahydrobiopterin loading test in hyperphenylalaninemia. Pediatr Res 30:435–438
Rahbeeni Z, Ozand PT, Rashed M et al (1994) 4-Hydroxybutyric aciduria. Brain Dev 16(Suppl):64–71
Ramus SJ, Forrest SM, Pitt DD et al (1999) Genotype and intellectual phenotype in untreated phenylketonuria patients. Pediatr Res 45(4 Pt 1):474–481
Rashed M, Ozand PT, Bucknall MP et al (1995) Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 38:324–331
Rashed MS, Bucknall MP, Little D et al (1997) Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem 43:1129–1141
Reichardt JK (1992) Genetic basis of galactosemia. Hum Mutat 1:190–196
Ris MD, Williams SE, Hunt MM et al (1994) Early-treated phenylketonuria: adult neuropsychologic outcome. J Pediatr 124:388–392
Riviello JJ Jr, Rezavni I, DiGeorge AM et al (1991) Cerebral edema causing death in children with maple syrup urine disease. J Pediatr 119:42–45
Robinson BH (1994) MtDNA and nuclear mutations affecting oxidative phosphorylation: correlating severity of clinical defect with extent of bioenergetic compromise. J Bioenerg Biomembr 26:311–316
Robinson BH, Oei J, Sherwood WG et al (1984) The molecular basis for the two different clinical presentations of classical pyruvate carboxylase deficiency. Am J Hum Genet 36:283–294
Saudubray JM, Charpentier C (1995) Clinical phenotypes: diagnosis/algorithms. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular genetic bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 327–400
Schmitt B, Steinmann B, Gitzelmann R et al (1993) Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor. Neurology 43:2422–2423
Schutgens RB, Bouman IW, Nijenhaus AA et al (1993) Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. Clin Chem 39:1632–1637
Schweitzer S, Shin Y, Jakobs C et al (1993) Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr 152:36–43
Smit GP (1993) The long-term outcome of patients with glycogen storage disease type 1a. Eur J Pediatr 152(Suppl 1):S52–S55
Sovik O (1993) Mitochondrial 2-methylacetoacetyl-CoA thiolase deficiency: an inborn error of isoleucine and ketone body metabolism. J Inherit Metab Dis 16:46–54
Stigsby B, Yarwoth SM, Rahbeeni Z et al (1994) Neurophysiologic correlates of organic acidemias: a survey of 107 patients. Brain Dev 16(Suppl):125–144
Surtees RAH, Matthews EE, Leonard JV (1992) Neurologic outcome of propionic acidemia. Pediatr Neurol 8:333–337
Tada K, Kure S (1993) Non-ketotic hyperglycinemia: molecular lesion, diagnosis and pathophysiology. J Inherit Metab Dis 16:691–703
Takanashi J, Fujii K, Sugita K et al (1999) Neuroradiologic findings in glutaric aciduria type II. Pediatr Neurol 20:142–145
Thoene JG (1999) Treatment of urea cycle disorders. J Pediatr 134:255–256
Thompson GN, Butt WW, Shann FA et al (1991) Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism. J Pediatr 118:879–884
Thuy LP, Belmont J, Nyhan WL (1999) Prenatal diagnosis and treatment of holocarboxylase synthetase deficiency. Prenat Diagn 19:108–112
Todo S, Strazl TE, Tzakis A et al (1992) Orthoptic liver transplantation for urea cycle enzyme deficiency. Hepatology 15:419–422
Trefz FK, Burgard P, Konig T et al (1993) Genotype-phenotype correlations in phenylketonuria. Clin Chim Acta 217:15–21
Tuchman M (1992) The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency. J Lab Clin Med 120:836–850
Tuchman M, Mauer SM, Holzknecht RA et al (1992) Prospective versus clinical diagnosis and therapy of acute neonatal hyperammonemia in two sisters with carbamyl phosphate synthetase deficiency. J Inherit Metab Dis 15:269–277
van Coster RN, Fernhoff PM, De Vivo DC (1991) Pyruvate carboxylase deficiency: a benign variant with normal development. Pediatr Res 30:1–4
van Spronsen FJ, Smit GPA, Wijburg FA et al (1995) Tyrosinaemia type 1: considerations of treatment strategy and experiences with risk assessment, diet and transplantation. J Inherit Metab Dis 18:111–114
Wanders RJA, van Roermund CWT, Schutgens RBH et al (1990) The inborn errors of peroxisomal β-oxidation. J Inherit Metab Dis 13:4–36
Wang BB, Xu YK, Ng WG et al (1998) Molecular and biochemical basis of galactosemia. Mol Genet Metab 63:263–269
Weglage J, Funders B, Wilken B et al (1993) School performance and intellectual outcome in adolescents with phenylketonuria. Acta Paediatr 82:582–586
Wellner VP, Sekura R, Meister A et al (1974) Glutathione synthetase deficiency, an inborn error of metabolism involving the gamma-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proc Natl Acad Sci USA 71:2505–2509
Wendel U, Langenbeck U, Lombeck I et al (1982a) Exchange transfusion in acute episodes of maple syrup urine disease: studies on branchedchain amino and keto acids. Eur J Pediatr 138:293–296
Wendel U, Langenbeck U, Lombeck I et al (1982b) Maple syrup urine disease – therapeutic use of insulin in catabolic states. Eur J Pediatr 139:172–175
Wexler ID, Hemalatha SG, McConnell J et al (1997) Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets: studies in patients with identical mutations. Neurology 49:1655–1661
Widhalm K, Koch S, Scheibenreiter S et al (1992) Long term follow-up of 12 patients with the late-onset variant of argininosuccinic acid lyase deficiency: no impairment of intellectual and psychomotor development during therapy. Pediatrics 89:1182–1184
Wilcken B, Hammond J, Silink M (1994) Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency. Arch Dis Child 70:410–412
Wilson GN (1991) Structure-function relationships in the peroxisome: implications for human disease. Biochem Med Metab Biol 46:288–298
Wolf B, Feldman GL (1982) The biotin-dependent carboxylase deficiencies. Am J Hum Genet 34:699–716
Wolf B, Heard GS (1991) Biotinidase deficiency. Adv Pediatr 38:1–21
Worthen H, Al Ashwal A, Ozand PT et al (1994) Comparative frequency and severity of hypoglycemia in selected organic acidemias, branched-chain amino acidemia, and disorders of fructose metabolism. Brain Dev 16(Suppl):81–85
Yamaguchi S, Orii T, Suzuki Y et al (1991) Newly identified forms of electron transfer flavoprotein deficiency in two patients with glutaric aciduria type II. Pediatr Res 29:60–63
Yamaguchi S, Indo Y, Coates PM et al (1993) Identification of very-long chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 34:111–113
Yap S, Naughten E (1998) Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years’ experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis 21:738–747
Yoshino M, Aoki K, Akeda H et al (1999) Management of acute metabolic decompensation in maple syrup urine disease: a multi-center study. Pediatr Int 41:132–137
Zammarchi E, Donati MA, Ciani F et al (1994) Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia. Neuropediatrics 25:274–276
Acknowledgments
Excellent and detailed reviews of the diseases discussed in this chapter can be found in The Metabolic and Molecular Bases of Inherited Disease edited by C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (New York, McGraw-Hill, 7th edition 1995). Suggested reading material for important aspects of each disease presented is listed in the sections below.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Ozand, P.T., Al-Essa, M. (2012). Disorders of Organic Acid and Amino Acid Metabolism. In: Elzouki, A.Y., Harfi, H.A., Nazer, H.M., Stapleton, F.B., Oh, W., Whitley, R.J. (eds) Textbook of Clinical Pediatrics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02202-9_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-02202-9_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02201-2
Online ISBN: 978-3-642-02202-9
eBook Packages: MedicineReference Module Medicine